These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32526601)

  • 1. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
    Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy.
    Moore S; Leung B; Wu J; Ho C
    J Thorac Oncol; 2019 Aug; 14(8):1430-1439. PubMed ID: 31002953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa - KINDLE Study.
    Jazieh AR; Sağlam EK; Önal HC; Abdelkader Y; Gaafar R; Dawoud E; Nassar M; Alshorbagy D; El Ashry H; Elsayed M
    Clin Lung Cancer; 2022 Jun; 23(4):364-373. PubMed ID: 35277345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
    Lee J; Ahn HK; Kim SW; Han JY; Lee SS; Park HS; Lee HW; Kim JH; Cho E; Huggenberger R; Cho BC
    Cancer Med; 2024 Apr; 13(7):e7174. PubMed ID: 38622869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study.
    Guan S; Sun J; Wang Y; Han S; Chen C; Yue D; Huang Y; Ren K; Wang J; Wang J; Zhao L
    Cancer Immunol Immunother; 2024 May; 73(7):120. PubMed ID: 38713243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study.
    Auliac JB; Greillier L; Martin E; Falcoz PE; Boisselier P; Ano S; Lefrançois M; Cortot A
    Respir Med Res; 2024 Jun; 85():101087. PubMed ID: 38657298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.
    Yusuf D; Walton RN; Hurry M; Farrer C; Bebb DG; Cheung WY
    Am J Clin Oncol; 2020 Sep; 43(9):615-620. PubMed ID: 32889830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.
    Agulnik J; Kasymjanova G; Pepe C; Hurry M; Walton RN; Sakr L; Cohen V; Lecavalier M; Small D
    Curr Oncol; 2020 Oct; 27(5):e459-e466. PubMed ID: 33173385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
    Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
    Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
    Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
    Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study.
    Horinouchi H; Atagi S; Oizumi S; Ohashi K; Kato T; Kozuki T; Seike M; Sone T; Sobue T; Tokito T; Harada H; Maeda T; Mio T; Shirosaka I; Hattori K; Shin E; Murakami H
    Cancer Med; 2020 Sep; 9(18):6597-6608. PubMed ID: 32730697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study.
    Guan S; Ren K; Zhang X; Yan M; Li X; Zhao L
    Radiat Oncol; 2023 Jul; 18(1):122. PubMed ID: 37491257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of unresectable stage III NSCLC: Real world cohort study and literature review.
    Verfaillie S; Lambrecht M; Berkovic P; Dooms C; Nackaerts K; Van de Velde AS; Vansteenkiste J; Wauters E
    Cancer Treat Res Commun; 2023; 36():100727. PubMed ID: 37307680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada.
    Seung SJ; Hurry M; Walton RN; Evans WK
    Curr Oncol; 2020 Aug; 27(4):e354-e360. PubMed ID: 32905267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
    Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
    Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.
    Lim HJ; Lee HY; Lee KS; Han J; Kwon OJ; Park K; Ahn YC; Kim BT; Shim YM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):77-85. PubMed ID: 25374409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
    Zemanova M; Pirker R; Petruzelka L; Zbozínkova Z; Jovanovic D; Rajer M; Bogos K; Purkalne G; Ceriman V; Chaudhary S; Richter I; Kufa J; Jakubikova L; Zemaitis M; Cernovska M; Koubkova L; Vilasova Z; Dieckmann K; Farkas A; Spasic J; Fröhlich K; Tiefenbacher A; Hollosi V; Kultan J; Kolarová I; Votruba J
    Radiol Oncol; 2020 May; 54(2):209-220. PubMed ID: 32463394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience.
    Mertsoylu H; Köse F; Sümbül AT; Sedef AM; Doğan Ö; Besen AA; Parlak C; Fındıkçıoğlu A; Muallaoğlu S; Sezer A; Sakallı H; Özyılkan Ö
    Med Sci Monit; 2015 Mar; 21():661-6. PubMed ID: 25731741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.